AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 73 filers reported holding AGILE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $176,000 | -61.6% | 841,118 | -10.4% | 0.00% | – |
Q4 2021 | $458,000 | -49.3% | 938,561 | -0.2% | 0.00% | -100.0% |
Q3 2021 | $903,000 | -54.8% | 939,979 | -37.5% | 0.00% | 0.0% |
Q2 2021 | $2,000,000 | +15.3% | 1,504,056 | +141.0% | 0.00% | -50.0% |
Q2 2020 | $1,735,000 | -32.8% | 624,190 | -55.0% | 0.00% | -66.7% |
Q1 2020 | $2,582,000 | +870.7% | 1,388,336 | +1203.8% | 0.01% | – |
Q4 2019 | $266,000 | +52.0% | 106,481 | -28.1% | 0.00% | – |
Q3 2019 | $175,000 | +56.2% | 148,138 | +256.0% | 0.00% | – |
Q4 2017 | $112,000 | -82.5% | 41,607 | -71.0% | 0.00% | -100.0% |
Q3 2017 | $639,000 | +30.9% | 143,326 | +10.0% | 0.00% | 0.0% |
Q2 2017 | $488,000 | +152.8% | 130,256 | +525.7% | 0.00% | – |
Q1 2015 | $193,000 | -80.2% | 20,819 | -81.4% | 0.00% | -100.0% |
Q2 2014 | $975,000 | – | 111,805 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 15,919,925 | $15,301,000 | 0.22% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 735,000 | $706,000 | 0.09% |
INVESTOR AB | 3,510,189 | $3,370,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 586,491 | $564,000 | 0.06% |
FIRST MIDWEST BANK TRUST DIVISION | 335,735 | $322,000 | 0.05% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 70,000 | $67,000 | 0.02% |
Summit Global Investments | 126,000 | $121,000 | 0.01% |
Ergoteles LLC | 211,611 | $203,000 | 0.01% |
GRIMES & COMPANY, INC. | 99,744 | $96,000 | 0.00% |
Kalos Management, Inc. | 17,749 | $15,000 | 0.00% |